Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02664883 · ClinicalTrials.gov registry record
Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer
A clinical trial of Healthy Subject and Metastatic Renal Cell Cancer, sponsored by University of Southern California.
- Active
- Registry status
- 37
- Enrollment target
- 1
- Study location
NCT02664883 is a study of Healthy Subject and Metastatic Renal Cell Cancer that is active but no longer recruiting, run by University of Southern California. The registered enrollment target is 37 participants, below the 246-participant average among 16 other Healthy Subject trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02664883, a study of Healthy Subject and Metastatic Renal Cell Cancer, is active but no longer recruiting, sponsored by University of Southern California.
- ACTIVE NOT RECRUITING
- Registry status
- 37 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot research trial studies the use of the Myeloid Derived Suppressor Cells Clinical Assay in finding and monitoring kidney cancer. Studying samples of blood and urine from patients with kidney cancer in the laboratory may aid doctors in the early detection of cancer, monitor tumor response to therapy, detect the presence of occult spreading of disease, and identify early return of disease.
Conditions Studied
Interventions
- PROCEDURE Computed Tomography
- PROCEDURE Magnetic Resonance Imaging
- OTHER Laboratory Biomarker Analysis
- OTHER Cytology Specimen Collection Procedure
Study Locations (1)
California
- USC / Norris Comprehensive Cancer Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2015-09-08 |
| Est. Completion | 2026-10-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02664883
The ClinicalTrials.gov registry entry for NCT02664883 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 246-participant average among 16 other Healthy Subject trials with a reported enrollment target (85% lower). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Healthy Subject appearing as the primary indexed condition, and to 4 interventions - of which Computed Tomography is the first listed.
NCT02664883 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02664883 about?
NCT02664883 is a clinical study titled "Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer". This pilot research trial studies the use of the Myeloid Derived Suppressor Cells Clinical Assay in finding and monitoring kidney cancer. Studying samples of blood and urine from patients with kidney cancer in the laboratory may aid doctors in the early detection of cancer, monitor tumor response to...
What is the current status of trial NCT02664883?
This trial is currently active not recruiting. The enrollment target is 37 participants. The study started on 2015-09-08. Estimated completion is 2026-10-29.
What conditions does trial NCT02664883 study?
This clinical trial studies the following conditions: Healthy Subject, Metastatic Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Recurrent Renal Cell Carcinoma.
What interventions are being tested in trial NCT02664883?
The interventions under investigation include: Computed Tomography (PROCEDURE), Magnetic Resonance Imaging (PROCEDURE), Laboratory Biomarker Analysis (OTHER), Cytology Specimen Collection Procedure (OTHER).
Who is sponsoring clinical trial NCT02664883?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02664883 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Subject
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects
RECRUITING · NA
-
Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
RECRUITING
-
Food Frequency Questionnaires in Estimating Food Nutrient Intake in Healthy Young Adults
ACTIVE NOT RECRUITING
-
Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients
ACTIVE NOT RECRUITING · NA
-
Physical Activity in Promoting Smoking Cessation in African Americans
ACTIVE NOT RECRUITING · NA
-
Eat, Move, Live Intervention in Reducing Chronic Disease Risk in Medically Vulnerable Communities
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.